|
⚲
|
| Keyboard |
| Christoph Westphal | |
|---|---|
| Firm | |
| Address | c/o Newleos Therapeutics, Inc 800 Boylston Street, Suite 1715 Boston, MA 02199 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Newleos Therapeutics Inc | 021-539081 | Director | 93.4 M of 93.4 M |
||
| Immunitas Therapeutics Inc | 021-411076 | Director | 29.1 M of 57.7 M |
||
| TScan Therapeutics Inc | 021-387638 | Director | 100.0 M of 100.0 M |
||
| Immuneid Inc | 021-386228 | Executive Officer | 17.1 M of 20.2 M |
||
| Werewolf Therapeutics Inc | 021-346661 | Director | 56.2 M of 56.2 M |
||
| TScan Therapeutics Inc | 021-345133 | Director | 23.3 M of 23.3 M |
||
| Pyxis Oncology Inc | 021-344177 | Director | 22.0 M of 22.0 M |
||
| Recros Medica Inc | 021-332906 | Director | 4.1 M of 10.0 M |
||
| Flex Pharma Inc | 021-222417 | Executive Officer | 16.2 M of 22.0 M |
||
| Verastem Inc | 021-213067 | Executive Officer | 3.9 M of 3.9 M |
||
| OvaScience Inc | 021-194187 | Director | 35.0 M of 35.0 M |
||
| Verastem Inc | 021-181480 | Executive Officer | 2.0 M of 2.0 M |
||
| OvaScience Inc | 021-180752 | Director | 4.9 M of 4.9 M |
||
| OvaScience Inc | 021-176335 | Director | 37.2 M of 37.2 M |
||
| Verastem Inc | 021-168567 | Executive Officer | 20.4 M of 20.4 M |
||
| Verastem Inc | 021-163437 | Executive Officer | 32.0 M of 32.0 M |
||
| Alnara Pharmaceuticals Inc | 021-123629 | Director | 20.0 M of 35.0 M |
||
| Longwood Management LLC | |||||
| Longwood Special Situations Fund LP | 021-500473 | Executive Officer | 157.8 M of 200.0 M |
169.1 M | |
| Longwood Fund VI LP | 021-414241 | Executive Officer | 94.5 M of 150.0 M |
106.8 M | |
| Longwood Fund V LP | 021-330977 | Executive Officer | 117.8 M of 117.8 M |
53.1 M | |
| Longwood Fund IV LP | 021-266740 | Executive Officer | of 90.0 M |
17.0 M | |